JY
WVE icon

Jeff Yass’s Wave Life Sciences WVE Stock Holding History

Jeff Yass’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$594K Sell
102,200
-138,400
-58% -$918K ﹤0.01% 9503
2026
Q1 		$1.74M Sell
240,600
-393,500
-62% -$5.13M ﹤0.01% 6492
2025
Q4 		$10.8M Buy
634,100
+620,300
+4,495% +$6.3M ﹤0.01% 2942
2025
Q3 		$101K Buy
+13,800
New +$112K ﹤0.01% 11557
2025
Q2 		– Sell
-81,700
Closed -$660K – 13834
2025
Q1 		$660K Sell
81,700
-21,100
-21% -$231K ﹤0.01% 8289
2024
Q4 		$1.27M Buy
102,800
+19,400
+23% +$259K ﹤0.01% 6384
2024
Q3 		$684K Buy
83,400
+41,900
+101% +$250K ﹤0.01% 7715
2024
Q2 		$207K Buy
41,500
+28,700
+224% +$164K ﹤0.01% 10282
2024
Q1 		$79K Sell
12,800
-1,400
-10% -$7.01K ﹤0.01% 11343
2023
Q4 		$71.7K Buy
+14,200
New +$75.9K ﹤0.01% 11534
2023
Q1 		– Sell
-11,200
Closed -$78.4K – 13596
2022
Q4 		$78.4K Buy
+11,200
New +$51.6K ﹤0.01% 11141
2021
Q4 		– Sell
-11,700
Closed -$57K – 14015
2021
Q3 		$57K Sell
11,700
-47,500
-80% -$288K ﹤0.01% 12306
2021
Q2 		$394K Sell
59,200
-341,900
-85% -$2.23M ﹤0.01% 10170
2021
Q1 		$2.25M Buy
401,100
+375,300
+1,455% +$3.61M ﹤0.01% 5636
2020
Q4 		$203K Sell
25,800
-100,700
-80% -$845K ﹤0.01% 10017
2020
Q3 		$1.07M Buy
126,500
+28,600
+29% +$313K ﹤0.01% 5940
2020
Q2 		$1.02M Buy
97,900
+23,500
+32% +$221K ﹤0.01% 5874
2020
Q1 		$697K Sell
74,400
-159,900
-68% -$1.36M ﹤0.01% 6207
2019
Q4 		$1.88M Buy
234,300
+193,800
+479% +$4.75M ﹤0.01% 4433
2019
Q3 		$831K Buy
40,500
+7,300
+22% +$167K ﹤0.01% 6108
2019
Q2 		$866K Buy
33,200
+300
+0.9% +$8.41K ﹤0.01% 6007
2019
Q1 		$1.28M Buy
+32,900
New +$1.33M ﹤0.01% 4536

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Jeff Yass's WVE Position: Q2 2026 in Review

Jeff Yass increased its Wave Life Sciences (WVE) stake by 15% in Q2 2026, buying an estimated $262K and bringing the position to 299,400 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #6810.

Jeff Yass first reported a position in WVE in Q1 2016 and has held it in 26 quarters since. The position peaked at $6.44M in Q4 2025. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Jeff Yass held 299,400 shares of Wave Life Sciences worth $1.74M as of Q2 2026.
  • Jeff Yass bought 39,575 Wave Life Sciences shares in Q2 2026, an estimated $262K.
  • Wave Life Sciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6810 holding.
  • Jeff Yass first reported a position in Wave Life Sciences in Q1 2016 and has held it in 26 quarters since.
  • Jeff Yass's Wave Life Sciences position peaked at $6.44M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.